Christopher Bunick, MD, PhD, is a physician-scientist practicing general medical and surgical dermatology at Yale Dermatology, and is an associate professor of dermatology at the Yale School of Medicine.
Moderate to Severe Plaque Psoriasis: An Overview of Biologic Agents
A brief review of biologic agents being used or evaluated in the setting of plaque psoriasis.
Moderate to Severe Plaque Psoriasis: What is the Standard of Care?
Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.
Plaque Psoriasis Case 1: Selecting a Therapeutic Class
The panel reviews therapeutic classes and their respective benefits in patients being treated for plaque psoriasis.
Plaque Psoriasis Case 1: Patient Counseling and Approaching Therapy
Centering discussion on a case of plaque psoriasis, experts share their experience with patient counseling and selecting therapy.
Understanding the Psychosocial Burden of Plaque Psoriasis
Considerations for the psychological and social impact that plaque psoriasis may have on a patient.
Challenges in Diagnosing Plaque Psoriasis
Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis
Identifying Clinical Manifestations of Plaque Psoriasis
Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.
Pathophysiology of Plaque Psoriasis and Targeted Therapies
A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.